AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Sectors:
Industries:
Analyst Ranking
Top 11%
#540 out of 5095 analysts
Average Return
+9.95%
Win Rate
50%69 out of 138
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +263.97% | $7.16 | $26.06 | 2024-11-06 - 2025-11-05 | Buy |
4d Molecular Therapeutics IncFDMT | +163.77% | $4.14 | $10.92 | 2025-03-03 - 2025-11-06 | Buy |
Arrowhead Pharmaceuticals IncARWR | +141.17% | $16.42 | $39.60 | 2025-08-08 - 2025-11-06 | Buy |
Uniqure NvQURE | +137.93% | $5.88 | $13.99 | 2024-01-16 - 2025-01-15 | Buy |
Avidity Biosciences IncRNA | +126.75% | $30.84 | $69.93 | 2025-01-21 - 2025-10-28 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dyne Therapeutics IncDYN | 4 | Buy | $30.00 | +64.79% | Maintains | 2 days ago |
Uniqure NvQURE | 7 | Buy | $45.00 | +63.58% | Maintains | 4 days ago |
Argenx SeARGX | 2 | Buy | $860.00 | +1.06% | Maintains | 8 days ago |
Ionis Pharmaceuticals IncIONS | 10 | Buy | $82.00 | +10.66% | Maintains | 9 days ago |
Fulcrum Therapeutics IncFULC | 2 | Hold | $7.00 | -8.50% | Maintains | 9 days ago |
Avidity Biosciences IncRNA | 3 | Hold | $72.00 | +3.18% | Downgrades | 11 days ago |
Intellia Therapeutics IncNTLA | 6 | Hold | $14.00 | +13.64% | Downgrades | 11 days ago |
Alnylam Pharmaceuticals IncALNY | 27 | Buy | $500.00 | +13.51% | Maintains | 2 months ago |
Regenxbio IncRGNX | 9 | Buy | $17.00 | +52.19% | Maintains | 3 months ago |
Ascendis Pharma AASND | 3 | Buy | $230.00 | +15.42% | Maintains | 3 months ago |
Arrowhead Pharmaceuticals IncARWR | 9 | Buy | $38.00 | -4.04% | Maintains | 3 months ago |
Crispr Therapeutics AgCRSP | 13 | Hold | $42.00 | -25.81% | Maintains | 3 months ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $4.00 | -6.54% | Maintains | 6 months ago |
Allogene Therapeutics IncALLO | 8 | Buy | $10.00 | +852.38% | Reiterates | 6 months ago |
Apellis Pharmaceuticals IncAPLS | 7 | Hold | $18.00 | -8.68% | Maintains | 6 months ago |
Moderna IncMRNA | 17 | Hold | $28.00 | +15.08% | Maintains | 6 months ago |
Lexeo Therapeutics IncLXEO | 5 | Buy | $20.00 | +137.53% | Maintains | 7 months ago |
Korro Bio IncKRRO | 7 | Buy | $95.00 | +191.68% | Maintains | 8 months ago |
Sangamo Therapeutics IncSGMO | 6 | Hold | $2.00 | +333.84% | Reiterates | 8 months ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $17.00 | +59.92% | Initiates Coverage On | 8 months ago |
Meiragtx Holdings PLCMGTX | 6 | Buy | $13.00 | +54.58% | Maintains | 8 months ago |
Verve Therapeutics IncVERV | 7 | Buy | $15.00 | +34.77% | Maintains | 8 months ago |
4d Molecular Therapeutics IncFDMT | 7 | Buy | $35.00 | +220.51% | Maintains | 8 months ago |
Beam Therapeutics IncBEAM | 7 | Hold | $26.00 | +12.31% | Maintains | 8 months ago |
Biomarin Pharmaceutical IncBMRN | 12 | Hold | $70.00 | +35.03% | Reiterates | 9 months ago |
Schlumberger LimitedSLB | 1 | Buy | $57.00 | +56.77% | Reiterates | 10 months ago |
Editas Medicine IncEDIT | 8 | Hold | $4.00 | +48.70% | Maintains | a year ago |
Bluebird Bio IncBLUE | 4 | Hold | $80.00 | +1,509.66% | Reiterates | a year ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Buy | $77.00 | N/A | Reiterates | a year ago |
Wave Life Sciences LtdWVE | 5 | Hold | $15.00 | N/A | Maintains | a year ago |
Caribou Biosciences IncCRBU | 5 | Buy | $14.00 | N/A | Reiterates | a year ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.